QQ客服 官方微博 反馈留言

	Phase II Study of S-1 plus Cisplatin as First-Line Therapy in Patients with Metastatic Esophageal Carcinoma
	Sun, Si; Yu, Hui; Wang, Huijie; Zhang, Hai; Wu, Xianghua; Wang, Jialei; Chang, Jianhua
刊名	ONCOLOGY RESEARCH AND TREATMENT
	2019
卷号	42期号:3
关键词	Esophageal cancer Chemotherapy Metastatic Squamous cell cancer, SCC
ISSN号	2296-5270
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3595321
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Sun, Si,Yu, Hui,Wang, Huijie,et al. Phase II Study of S-1 plus Cisplatin as First-Line Therapy in Patients with Metastatic Esophageal Carcinoma[J]. ONCOLOGY RESEARCH AND TREATMENT,2019,42(3).
APA	Sun, Si.,Yu, Hui.,Wang, Huijie.,Zhang, Hai.,Wu, Xianghua.,...&Chang, Jianhua.(2019).Phase II Study of S-1 plus Cisplatin as First-Line Therapy in Patients with Metastatic Esophageal Carcinoma.ONCOLOGY RESEARCH AND TREATMENT,42(3).
MLA	Sun, Si,et al."Phase II Study of S-1 plus Cisplatin as First-Line Therapy in Patients with Metastatic Esophageal Carcinoma".ONCOLOGY RESEARCH AND TREATMENT 42.3(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。